Institutional investors purchased a net $683.0 thousand shares of GHDX during the quarter ended March 2018 and now own 92.35% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
BAKER BROS. ADVISORS LP Bought 362.0 Thousand shares of Genomic Health Inc
POINT72 ASSET MANAGEMENT LP Bought 223.8 Thousand shares of Genomic Health Inc
SSGA FUNDS MANAGEMENT, INC. Bought 199.2 Thousand shares of Genomic Health Inc